Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, United States of America.
PLoS One. 2012;7(12):e51407. doi: 10.1371/journal.pone.0051407. Epub 2012 Dec 7.
Histone methylation regulates normal stem cell fate decisions through a coordinated interplay between histone methyltransferases and demethylases at lineage specific genes. Malignant transformation is associated with aberrant accumulation of repressive histone modifications, such as polycomb mediated histone 3 lysine 27 (H3K27me3) resulting in a histone methylation mediated block to differentiation. The relevance, however, of histone demethylases in cancer remains less clear. We report that JMJD3, a H3K27me3 demethylase, is induced during differentiation of glioblastoma stem cells (GSCs), where it promotes a differentiation-like phenotype via chromatin dependent (INK4A/ARF locus activation) and chromatin independent (nuclear p53 protein stabilization) mechanisms. Our findings indicate that deregulation of JMJD3 may contribute to gliomagenesis via inhibition of the p53 pathway resulting in a block to terminal differentiation.
组蛋白甲基化通过组蛋白甲基转移酶和去甲基酶在谱系特异性基因之间的协调相互作用来调节正常干细胞命运决定。恶性转化与抑制性组蛋白修饰(如多梳介导的组蛋白 3 赖氨酸 27(H3K27me3)的异常积累有关,导致组蛋白甲基化介导的分化阻滞。然而,组蛋白去甲基酶在癌症中的相关性尚不清楚。我们报告说,JMJD3 是一种 H3K27me3 去甲基酶,在神经胶质瘤干细胞(GSCs)的分化过程中被诱导,它通过染色质依赖(INK4A/ARF 基因座激活)和染色质独立(核 p53 蛋白稳定)机制促进分化样表型。我们的发现表明,JMJD3 的失调可能通过抑制 p53 途径导致终末分化阻滞而促进神经胶质瘤发生。